BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 06/01/1999

FDA Withdraws Approval of Dipyridamole Drugs Due to Lack of Evidence

The FDA is withdrawing conditional approval of certain dipyridamole drug products and declaring three unapproved products unlawful, citing insufficient evidence of their effectiveness in treating chronic angina pectoris.

Source: Federal Register — Food and Drug AdministrationOpen original release →